# Cognitive Function in Melanoma Patients Treated With Adjuvant Immune Checkpoint Inhibitors

> **NCT04565769** · — · ACTIVE_NOT_RECRUITING · sponsor: **Aarhus University Hospital** · enrollment: 100 (actual)

## Conditions studied

- Melanoma
- Cognitive Impairment
- Fatigue
- Sleep
- Depression, Anxiety
- Quality of Life
- Inflammation
- Sickness Behavior
- Cancer-related Cognitive Impairment

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04565769
- **Lead sponsor:** Aarhus University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-11-12
- **Primary completion:** 2025-03
- **Final completion:** 2025-03
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04565769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04565769, "Cognitive Function in Melanoma Patients Treated With Adjuvant Immune Checkpoint Inhibitors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04565769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*